microfluidic 48 48 access array ifc (fluidigm)
fluidigm is a verified supplier 
fluidigm manufactures this product 
93
Structured Review
fluidigm
microfluidic 48 48 access array ifc
Microfluidic 48 48 Access Array Ifc, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 843 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microfluidic+48+48+access+array+ifc/Access+Array/pmc07756920-54-26-31
Average 93 stars, based on 843 article reviews
Microfluidic 48 48 Access Array Ifc, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 843 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microfluidic+48+48+access+array+ifc/Access+Array/pmc07756920-54-26-31
Average 93 stars, based on 843 article reviews
microfluidic 48 48 access array ifc - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
Multiplex Assay:Article Title: Germline variation of Ribonuclease H2 genes in ovarian cancer patients Article Snippet: .. For the multiplex PCR, each genomic DNA sample was normalised to a concentration of ~ 100 ng/μl, as measured by NanoDrop photometry, and loaded onto a Polymerase Chain Reaction:Article Title: Germline variation of Ribonuclease H2 genes in ovarian cancer patients Article Snippet: .. For the multiplex PCR, each genomic DNA sample was normalised to a concentration of ~ 100 ng/μl, as measured by NanoDrop photometry, and loaded onto a Concentration Assay:Article Title: Germline variation of Ribonuclease H2 genes in ovarian cancer patients Article Snippet: .. For the multiplex PCR, each genomic DNA sample was normalised to a concentration of ~ 100 ng/μl, as measured by NanoDrop photometry, and loaded onto a Article Title: Rare ATAD5 missense variants in breast and ovarian cancer patients. Article Snippet: ATAD5/ELG1 is a protein crucially involved in replication and maintenance of genome stability.. ATAD5 has recently been identified as a genomic risk locus for both breast and ovarian cancer through genomewide association studies.. We aimed to investigate the spectrum of coding ATAD5 germ-line mutations in hospital-based series of patients with triple-negative breast cancer or serous ovarian cancer compared with healthy controls. |